The upcoming big FDA 2-day public stem cell meeting next week is generating a lot of interest within the stem cell community and also with members of the media. I expect there to be tons of coverage, which should be a good thing (note that there’s a different FDA stem cell meeting tomorrow). If you can’t make tomorrow’s stem cell meeting in person and it is now closed to additional in-person participants, you can watch the webcast here. Amongst the many speakers on the agenda for next …Read More
There’s a big FDA stem cell meeting coming along next week that has gotten much attention, but many people didn’t realize there’s also an FDA meeting on stem cells this week too in three days on September 8th. I pasted this week’s meeting schedule at the bottom of this post from the FDA page. The meeting is a workshop entitled, “Public Workshop: Scientific Evidence in the Development of Human Cells, Tissues, and Cellular and Tissue-Based Products Subject to Premarket Approval”. The meeting next week on September …Read More
The stem cell clinic trial being run by Asterias Biotherapeutics for spinal cord injury (SCI) reported (via CIRM) some preliminary very good news as it is so far seems safe and will be expanded to involve more patients. In the next phase, reportedly “Asterias is now looking to enroll 5-8 patients for this 20 million cell phase.” You can also read the company’s PR on this development here. CIRM’s report by Kevin McCormack on this advance also included a window into the personal story of …Read More
I’ll be on NPR’s @hereandnow w/Robin Young in about 40 minutes talking stem cell clinics. #Stemcell clinics thrive in US despite lack of @US_FDA regs. Is it #SnakeOil? @Pknoepfler thinks so. https://t.co/NxJ5z3IVGw @hereandnow — Karyn Miller-Medzon (@KBMM) September 1, 2016 Listen in if you have the chance and the segment will also be archived on their website.